Skip to content

Anxiety: all studies

Page 598 of 769: studies 5,971 to 5,980 of 7,689, newest first. Back to the anxiety overview

Research

Efficacy of low-dose ketamine infusion in anxious vs nonanxious depression: revisiting the Adjunctive Ketamine Study of Taiwanese Patients with Treatment-Resistant Depression

CNS Spectrums August 1, 2021 Mu-Hong Chen, Wei-Chen Lin, Hui-Ju Wu et al.

AbstractBackgroundThe antidepressant effect of low-dose ketamine infusion on Taiwanese patients with anxious vs nonanxious treatment-resistant depression (ANX-TRD vs NANX-TRD) has remained unknown.MethodsIn total, 71 patients with TRD were randomized to three groups. Each group had participants who received saline infusions mixed with 0 (a normal saline infusion), 0.2, and 0.5 mg/kg of...

Philosophy of Psychedelics

Oxford University Press eBooks August 1, 2021 Chris Letheby

Philosophy of Psychedelics is the first scholarly monograph in English devoted to the philosophical analysis of psychedelic drugs. Its central focus is the apparent conflict between the growing use of psychedelics in psychiatry and the philosophical worldview of naturalism, which holds that the natural world is all that exists. The book reviews scientific evidence that psychedelics such as...

On the need for a natural philosophy of psychedelics

Philosophy of Psychedelics August 1, 2021 Chris Letheby 1 citation

‘On the need for a natural philosophy of psychedelics’ provides a brief overview of the history of psychedelics in science and psychiatry, and a detailed review of recent evidence for their therapeutic and transformative efficacy. The chapter reviews clinical trials showing that one or two controlled psychedelic experiences can durably reduce symptoms of anxiety, depression, and addiction, and...

Leveraging a Consumer-Based Product to Develop a Cancer-Specific Mobile Meditation App: Prototype Development Study (Preprint)

July 28, 2021 Jennifer Huberty, N. Bhuiyan, Taylor L Neher et al.

BACKGROUND Mobile meditation apps may offer a long-term, accessible, and effective solution for ongoing symptom management in cancer patients/survivors. However, there are currently no commercial cancer-specific meditation apps that reflect cancer specialist expertise, input from cancer patients/survivors, and features and content specific to cancer patients’/survivors’ needs. OBJECTIVE The aim...

Recreation and Realization: Reported Motivations of Use Among Persons Who Consume Psychedelics in Non-Clinical Settings

July 26, 2021 Cindy Brooks Dollar 8 citations

Psychedelic research is said to be going through a renaissance with widespread public and political attention on psychedelics' ability to clinically resolve various medicalized issues.The prevailing cultural narrative of psychedelics almost touts it as a panacea when used in regulated, clinical settings under the supervision of a trained guide.While clinical studies are certainly informative,...

DOI: 10.21428/88de04a1.cb6fef95 (opens in new tab) Recreation Realization probability

Trends and Developments in Mindfulness Research over 55 Years: A Bibliometric Analysis of Publications Indexed in Web of Science

Mindfulness July 16, 2021 Anuradha Baminiwatta, Indrajith Solangaarachchi

This study aimed to identify historical developments, active research areas, and emerging trends within scientific literature on mindfulness published so far, using bibliometric methods. We also aimed to identify prominent journals, authors, organizations, and countries in the field of mindfulness. Articles or reviews which mention mindfulness in the title, abstract, or keywords were identified...

Who is blind in psychedelic research? Letter to the editor regarding: blinding and expectancy confounds in psychedelic randomized controlled trials

Expert Review of Clinical Pharmacology July 6, 2021 E. Schenberg

Dear Editors, Unblinding is an important confounding in pharmacological research potentially affecting rigor and objectivity of the scientific data underlying evidence-based medicine. Therefore, I want to commend the work by Muthukumaraswamy et al. [1] reporting on this problem in clinical trials with psychedelics (Ketamine, LSD, psilocybin and ayahuasca), which are rapidly becoming a focus of...

A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear

The International Journal of Neuropsychopharmacology July 5, 2021 Sven Melker Hagsäter, Robert Pettersson, Christopher Pettersson et al. 29 citations

Abstract Background Though drugs binding to serotonergic 5-HT2A receptors have long been claimed to influence human anxiety, it remains unclear if this receptor subtype is best described as anxiety promoting or anxiety dampening. Whereas conditioned fear expressed as freezing in rats is modified by application of 5-HT2A–acting drugs locally into different brain regions, reports on the effect of...

An Observational, Longitudinal Study of Cognition in Medical Cannabis Patients over the Course of 12 Months of Treatment: Preliminary Results

Journal of the International Neuropsychological Society July 1, 2021 Kelly A. Sagar, M. Dahlgren, Ashley M. Lambros et al.

Abstract Objective: Cannabis use has increased dramatically across the country; however, few studies have assessed the long-term impact of medical cannabis (MC) use on cognition. Studies examining recreational cannabis users generally report cognitive decrements, particularly in those with adolescent onset. As MC patients differ from recreational consumers in motives for use, product selection,...

In the twilight zone: An epidemiological study of sleep-related hallucinations.

Comprehensive Psychiatry July 1, 2021 Josef J Bless, Kenneth Hugdahl, Bodil Kråkvik et al.

Few studies have investigated hallucinations that occur at the onset/offset of sleep (called hypnagogic/hypnopompic hallucinations; HHHs), despite the fact that their prevalence in the general population is reported to be higher than the prevalence of daytime hallucinations. We utilized data from an epidemiological study to explore the prevalence of HHHs in various modalities. We also...

DOI: 10.1016/j.comppsych.2021.152247 (opens in new tab) Full text (opens in new tab) Auditory Epidemiological Hallucinations Hypnagogic +3